Cargando…

High Expression of Urokinase-Type Plasminogen Activator Is Associated with Lymph Node Metastasis of Invasive Ductal Carcinoma of the Breast

PURPOSE: In the present study, we evaluated the levels of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1) by performing immunohistochemical staining to determine whether they were reliable prognostic markers in patients with breast cancer. METHODS: Demographi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eun Young, Do, Sung-Im, Hyun, Keehoon, Park, Yong Lai, Kim, Dong-Hoon, Chae, Seoung Wan, Sohn, Jin Hee, Park, Chan Heun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929256/ https://www.ncbi.nlm.nih.gov/pubmed/27382391 http://dx.doi.org/10.4048/jbc.2016.19.2.156

Ejemplares similares

Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas
por: Do, Sung-Im, et al.
Publicado: (2013)

Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomas.
por: Jang, Kee Taek, et al.
Publicado: (2002)

Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer
por: Leissner, Philippe, et al.
Publicado: (2006)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer
por: Kim, Tae-Dong, et al.
Publicado: (2006)

Coexistence of metastatic thyroid cancer and tuberculosis in a single neck lymph node: a rare association
por: Min, Kyueng-Whan, et al.
Publicado: (2018)

Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas
por: Shin, Jaehoon, et al.
Publicado: (2020)

Metastatic lymph node in gastric cancer; Is it a real distant metastasis?
por: Lim, Do Hyoung, et al.
Publicado: (2010)

Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis
por: Suh, Yun-Suhk, et al.
Publicado: (2015)

Feasibility of sentinel lymph node biopsy in breast cancer patients clinically suspected of axillary lymph node metastasis on preoperative imaging
por: Kwak, Hee Yong, et al.
Publicado: (2013)

Prognostic significance of expression of epithelial-mesenchymal transition driver brachyury in breast cancer and its association with subtype and characteristics
por: Lee, Kwan Ho, et al.
Publicado: (2018)

The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer
por: Lee, Kwan Ho, et al.
Publicado: (2018)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
por: Hosen, S. M. Zahid, et al.
Publicado: (2022)

Fibroadenoma progress to ductal carcinoma in situ, infiltrating ductal carcinoma and lymph node metastasis? Report an unusual case
por: Wu, Yu-Ting, et al.
Publicado: (2017)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
por: Tada, Keiichiro, et al.
Publicado: (2010)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Ductal Carcinoma In Situ and Sentinel Lymph Node Biopsy
por: Son, Bok Kyoung, et al.
Publicado: (2011)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer
por: Shin, Na Ri, et al.
Publicado: (2012)

Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts
por: Andersen, Lise Mari K., et al.
Publicado: (2017)

Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma
por: Suzuki, Yukie, et al.
Publicado: (2020)

Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2019)

Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2022)

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
por: Kwon, Ji Hyun, et al.
Publicado: (2010)

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Initial Axillary Lymph Node Metastasis after Primary Systemic Therapy
por: Kang, Eunyoung, et al.
Publicado: (2011)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

Nanoparticles for Lymph Node-Directed Delivery
por: Lee, Jaeseong, et al.
Publicado: (2023)

Frequency and Predictive Factors of Lymph Node Metastasis in Mucosal Cancer
por: Nam, Myung Jin, et al.
Publicado: (2010)

Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
por: Heynekamp, Justin J, et al.
Publicado: (2006)

Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts
por: Chao, Shih-Chun, et al.
Publicado: (2011)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
por: Ierodiakonou, Despo, et al.
Publicado: (2016)

Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
por: Merino, Paola, et al.
Publicado: (2018)

Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.
por: Hong, S. I., et al.
Publicado: (1996)

Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
por: Sugioka, Koji, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ecvh25880b74os7p0q957uhrmn